Below you will find editorial articles published on PEPTONIC medical’s activities, the development of the drug Vagitocin® and benefits of the hormone oxytocin. The material is presented in chronological order.
2017-05-24, Life Science Sweden, Mikael Mildén
Peptonic satsar receptfritt
När gelen mot vaginal atrofi visade sig fungera lika bra utan den aktiva substansen oxytocin, väljer Peptonic att lansera den receptfritt.
